The utility of 0.5% apraclonidine in the diagnosis of Horner syndrome [1] (multiple letters)

Archives of Ophthalmology

Volumn 123, Issue 4, 2005, Pages 578-

  Brown, Sandra M ^a   Bacal, Darron ^b  

^a TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER SCHOOL OF MEDICINE   (United States)

^b Eye Physicians and Surgeons   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APRACLONIDINE; ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; CLONIDINE; DIAGNOSTIC AGENT; DRUG DERIVATIVE; EYE DROPS;

ANISOCORIA; CHILD; CHILDHOOD DISEASE; DRUG FORMULATION; HORNER SYNDROME; HUMAN; LETTER; NEUROBLASTOMA; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SIDE EFFECT; NOTE;

ADRENERGIC ALPHA-AGONISTS; ANISOCORIA; CLONIDINE; HORNER SYNDROME; HUMANS; OPHTHALMIC SOLUTIONS;

EID: 16844380873     PISSN: 00039950     EISSN: None     Source Type: Journal    
DOI: 10.1001/archopht.123.4.578-a     Document Type: Letter

References (0)